Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02466061 · ClinicalTrials.gov registry record · NA
TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 207
- Enrollment target
NCT02466061: Completed NA study, sponsored by Fred Hutchinson Cancer Center.
NCT02466061 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 207 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02466061, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 207 participants
- Enrollment target
Study Summary
This randomized, controlled study evaluates the efficacy of weigh loss interventions in endometrial cancer survivors, using novel technology-based weight loss platforms. This is a multi-site, pilot feasibility study which will provide preliminary data to support a larger NIH funded, mult-center trial.
Primary Outcome
Change in weight (in kilograms) of study participants randomized to one of three weight loss intervention programs will be assessed. Measurement of this change will be evaluated from weights taken at baseline (randomization) and six months, the conclusion of the intervention program.
Interventions
- BEHAVIORAL Telemedicine Weight Management plus Wi-Fi Scale (Arm A)
- BEHAVIORAL Text for Diet (Text4Diet) Group (Arm B)
- BEHAVIORAL Enhanced Usual Care Group (Arm C)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 207 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-06 |
| Phase | NA |
What the finished NCT02466061 record still lists
NCT02466061 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 3 interventions - of which Telemedicine Weight Management plus Wi-Fi Scale (Arm A) is the first listed.
NCT02466061 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02466061 about?
NCT02466061 is a clinical study titled "TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors". This randomized, controlled study evaluates the efficacy of weigh loss interventions in endometrial cancer survivors, using novel technology-based weight loss platforms. This is a multi-site, pilot feasibility study which will provide preliminary data to support a larger NIH funded, mult-center tria...
What is the current status of trial NCT02466061?
This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2014-07. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02466061?
The interventions under investigation include: Telemedicine Weight Management plus Wi-Fi Scale (Arm A) (BEHAVIORAL), Text for Diet (Text4Diet) Group (Arm B) (BEHAVIORAL), Enhanced Usual Care Group (Arm C) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02466061?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02466061's enrollment target sits among peer trials
207 499th of 2000 higher than 1,502 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04353778 · 207 participants · Phase 1
Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV
- NCT05875805 · 207 participants · NA
A Telehealth Advance Care Planning Intervention
- NCT06254950 · 207 participants · Phase 2
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
- NCT06904274 · 207 participants · Phase 3
Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia